Publications by authors named "Ali Calderon-Aparicio"

Claim this Profile
S
Standardizing caloric restriction for preclinical cancer research.
Jenna L Jacoby, Ali Calderon Aparicio, Noëlle B François, Mehek Thapar, Sara E Burke

Biotechniques· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
S6K1 Controls DNA Damage Signaling Modulated by the MRN Complex to Induce Radioresistance in Lung Cancer.
Ali Calderon-Aparicio, Jun He, Nicole L Simone

Int J Mol Sci· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate cancer: Alternatively spliced mRNA transcripts in tumor progression and their uses as therapeutic targets.
Ali Calderon-Aparicio, Bi-Dar Wang

Int J Biochem Cell Biol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Roles of regulator of chromosome condensation 2 in cancer: Beyond its regulatory function in cell cycle.
Ali Calderon-Aparicio, Ann M Bode

Oncol Rev· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen-related receptor alpha directly binds to p53 and cooperatively controls colon cancer growth through the regulation of mitochondrial biogenesis and function.
Humberto De Vitto, Joohyun Ryu, Ali Calderon-Aparicio, Josh Monts, Raja Dey

Cancer Metab· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RCC2 Promotes Esophageal Cancer Growth by Regulating Activity and Expression of the Sox2 Transcription Factor.
Ali Calderon-Aparicio, Hiroyuki Yamamoto, Humberto De Vitto, Tianshun Zhang, Qiushi Wang

Mol Cancer Res· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision oncology in Latin America: current situation, challenges and perspectives.
Ali Calderón-Aparicio, Andrea Orue

Ecancermedicalscience· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticancer response to disulfiram may be enhanced by co-treatment with MEK inhibitor or oxaliplatin: modulation by tetrathiomolybdate, KRAS/BRAF mutations and c-MYC/p53 status.
Ali Calderon-Aparicio, Alejandro Cornejo, Andrea Orue, Manuel Rieber

Ecancermedicalscience· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disulfiram anti-cancer efficacy without copper overload is enhanced by extracellular H2O2 generation: antagonism by tetrathiomolybdate.
Ali Calderon-Aparicio, Mary Strasberg-Rieber, Manuel Rieber

Oncotarget· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis